Our findings suggest that LTFe exerts tumor-suppressive effects by modulating chromatin architecture, leading to the transcriptional activation of LTF, which in turn inhibits prostate cancer proliferation in both in vitro and in vivo models. Here, LTF is linked to prostate cancer.